-
FHU Mosaic²
2025-2029 Web site : https://fhu-mosaic.com MOSAIC² objective is to elucidate cancer heterogeneity across various types of cancers, and to contribute to the advanced understanding of the intricate interplay between tumor and host environment by an augmented imaging approach. MOSAIC² aims to address clinical challenges (poor prognostic cancers, rare targetable genetic alterations, and unpredictable response to therapies) and new technological challenges including limited access to multiscale and multicentric curated data, lack of integrative multiscale imaging analysis, and the…
-
FHU “FOR LIFE”
FédératiOn de Recherche pour la mise en Lumière par l’Imagerie du FoEtus Congenital anomalies affect 1% to 2% of pregnancies. Placental dysfunction also complicates 3% to 10% of pregnancies, often resulting in fetal growth retardation. All these anomalies can have a severe impact on the unborn child, with consequences well into adulthood. After rapid progress over the past 50 years, we have reached a plateau in managing these disorders. The…
-
MALDIBANK
Multi-domain Open MALDI Spectra Archive for Identification of Microorganisms 2025-2029 Funding: European HORIZON Research and Innovation Actions Web site: https://cordis.europa.eu/project/id/101188201 Microbes are essential to life, yet their vast diversity remains underappreciated despite their critical role in health, ecosystems, and industries like agriculture and food safety. Accurate microbial identification is key to addressing global challenges such as climate change, epidemics and food security. While matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry…
-
RXCIPHER
Start date: 2025 Funding: Sorbonne Université This project aims to improve drug database management by proposing an advanced structuring of drug information and further automation of the database construction. By further structuring information, the resulting database can take into account the patient’s context in a more comprehensive manner, thus reducing unnecessary alerts and improving the safety of medical prescriptions. Winner of a challenge organized by the French National Authority for…
-
Trajectome
Funding: Inserm, program MESSIDORE (Méthodologie des Essais cliniques Innovants, Dispositifs, Outils et Recherches Exploitant les données de santé et biobanques) Starting date: 2025 Trajectome is a collaborative project between mental healthcare professionals and scientists who will gather their efforts for the development of new tools using existing data. It will especially bring new tools to allow the integration of heterogeneous existing database as well as extraction of structured data from unstructured texts…
-
PARTAGES
2024-2027 Funding: Bpifrance The “PARTAGES” project, led by a consortium of 32 partners, including research laboratories, healthcare institutions, and deep tech companies, is a recipient of the France 2030 funding for generative AI. Coordinated by the Health Data Hub (HDH), the initiative aims to leverage generative AI to optimize healthcare professionals’ workflows, focusing on strategic applications like information extraction, medical summary generation, and clinical decision support. The project brings together…
-
INDICATE
2024-2029 Funding: European Union’s Digital Europe 2023 programme Web site: https://indicate-europe.eu/ Press release: https://indicate-europe.eu/news/launch-of-indicate-connecting-intensive-care-data-across-europe/ Linkedin: https://www.linkedin.com/company/indicate-eu X: https://x.com/IndicateEU INDICATE is a pioneering European initiative designed to enhance data access and sharing between intensive care units across Europe. INDICATE aims to advance patient-centered care and promoting ethically responsible data use and the development and implementation of trustworthy AI models. In the coming years, we will collaborate with organizations across the European healthcare sector to improve patient…
-
Itou – PostGenAI@Paris
2024 – 2029 Funding : France 2030 Limics is a partner in the PostGenAI@Paris cluster, a project led by Sorbonne University, which was selected from among nine research centers in the « IA-Cluster » call for expressions of interest, with a budget of €35 million over 5 years. https://scai.sorbonne-universite.fr/public/news/view/ca27c448b95463fedf46/7 “Itou” is part of this cluster and concerns the automatic creation of cohorts of similar patients based on medical reports from the AP-HP…
-
Phares 2: Social media and pharmacovigilance
2024 – 2026 Funding: ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé) Title : A processing chain for social media data and its application to pharmacovigilance Spontaneous reports of potentially drug-related adverse events, provided by healthcare professionals and patients, are the main source of information on the safety of drug use. Early research on social media in pharmacovigilance hypothesized that they could address the main limitation…
-
RHU AI-Triomph
2024 – 2029 The hospital-university health research program (RHU) run by the ANR aims to support translational health and clinical research projects. The RHU AI-Triomph (Artificial Intelligence – clinical TRIals Optimization for oncology with Multimodal PatHology) is coordinated and led by Prof. Magali Svrcek, Department of Anatomy and Cytology Pathology, Hôpital Saint-Antoine, AP-HP, AP-HP.Sorbonne Université. The other two co-sponsors of this project are Pr Jean-Baptiste Bachet, Hepato-gastroenterology Department, Pitié-Salpêtrière Hospital,…
-
SMeLT : Similarity Measure Learning for analogical Transfer
2023 – 2026 Funded by ANR https://smelt.irsan.eu/ The aim of SMeLT is to provide a methodology to learn a similarity measure that is optimized for a given analogical transfer task.Among the different tasks that computational analogy systems implement, the transfer task matches a predictive and hypothetical inference in which some knowledge is extrapolated from a similar situation in order to interpret a new situation and complete its description.By providing a…
-
EUCAIM
2023 – 2026 European Commission: European Cancer Imaging Initiative https://www.eibir.org/projects/eucaim/ EUropean Federation for CAncer IMages (EUCAIM) is the cornerstone of the European Commission-initiated European Cancer Imaging Initiative, a flagship of Europe’s Beating Cancer Plan (EBCP), which aims to foster innovation and deployment of digital technologies in cancer treatment and care to achieve more precise and faster clinical decision making, diagnostics, treatment and predictive medicine for cancer patients. The 4-year project started…
-
Integrated cancer research site CURAMUS
2023 – 2028 Funded by the French National Cancer Institute (INCa) Accueil The SiRIC CURAMUS was accredited again in 2023 by the French National Cancer Institute (INCa) and led by the AP-HP.Sorbonne University Hospital Group (Pitié Salpêtrière, Saint-Antoine, Tenon, Trousseau, Rothschild, Charles-Foix, La Roche-Guyon) and by Sorbonne University under the federation of the University Cancer Institute (IUC), in association with their institutional partners, Inserm and CNRS. SiRIC CURAMUS aims to…
-
CDE.AI
2022 – 2028 ANR funding: Priority research program on Rare Diseases CDE.AI: Artificial Intelligence at the service of common data elements for rare diseases The BNDMR (Base de Données Maladies Rares) evaluates the management of rare diseases, by collecting Common Data Elements. These elements are collected manually. Our aim is to create CDE.ai, a set of natural language processing (NLP) algorithms that automatically fill in the CDM collection forms, directly…
-
Medication Review Support – ABiMed
2020 – 2024 Funded by ANR Decision support tools for medication review and polypharmacy management Polypharmacy is a major public health problem. It causes adverse events and drug-drug interactions, but it also has an important cost for health insurances. A solution is the medication review: a pharmacist interviews the patient, reviews his medications and simplify the treatment, by removing non-mandatory drugs or those responsible for adverse events. Medication review is…
-
Smart Ultrasound in Obstetrics and Gynecology (SUOG)
2020 – 2024 EIT Health’s innovation programme Home SUOG Screening in early pregnancy for foetal abnormalities is an established part of routine care in Western countries. If the screening identifies an unusual feature (such as foetal malformation, or a growth anomaly), clinicians must refer the patient for an expert scan to decide a prognosis and organise care. However, there’s a lack of expert resource for those second mandatory scans. Some screening…
-
Open resources and methodologies for the detection of drug-drug interaction in clinical data warehouses – REMIAMES
2019 – 2023 Funded by ANR The existence of drug interactions in prescriptions is a risk for the patient and a reflection of improvable practices. These problems have already been quantified by studies on health care data. Nevertheless, to be credible and reproducible, these studies must have a rigorous methodology. Indeed, the way to look for drug interactions, the reference systems used, the available data (dosage, patient context …), will…
